Get the word out. Share this event with your colleagues. Click to post.

Emerging Issues in Life Science Cross-Border Initiatives

Emerging Issues in Life Science Cross-Border Initiatives
June 28, 2023 | 5:30 pm – 7:00pm  | Q & A and Networking 7:00pm – 8:00pm
Online registration is now closed. Please call Customer relations at 212 382 6663 to register or for assistance.

Format: In-Person

Program Fee:
Free for Members and Non-Lawyers | $15 Non-Members
Non-Lawyers please call Customer Relations at 212-382-6663 to register. 

Description:
Join us for a discussion on the emerging issues in life science cross-border transactions, especially focusing on the pharmaceutical licensing transactions (license-in/out) in China, key considerations for Chinese biotech companies to go public, and hot Chinese regulatory issues on clinical trials, registrational pathway, and human genetic resources (HGR).  

Moderator:
Aaron GU, Han Kun Law Offices

Speakers:
Ian Woo, President and Chief Financial Officer, Everest Medicines
Enna Weng, Managing Director,  Freedom Capital Markets
Alan Wang, PhD, Counsel, Goodwin & Procter LLP
Thomas Hou, Executive Director, Associate General Counsel, Iveric Bio

Sponsoring Committee:
Asian Affairs, Dih-Lin Wong, Chair

Co-Sponsoring Organizations:
Asia Practice Committee, Asian American Bar Association of New York
China Legal Education and Career Seminar Series
When
6/28/2023
Where
New York City Bar Association 42 West 44th Street New York, NY 10036

Please Sign In to Register